Ten testing updates:
- HHS overrides states, lets all pharmacists give COVID-19 tests
New HHS guidance overrides state and local rules that prevented pharmacists from administering COVID-19 diagnostic tests. - FDA approves another at-home COVID-19 test
The FDA granted emergency use authorization to a second COVID-19 diagnostic test that allows patients to collect samples using nasal swabs. - FDA reviewing accuracy of Abbott coronavirus test
Abbott’s COVID-19 diagnostic test may return false negatives, the FDA warned. - LabCorp, Quest expand COVID-19 testing
LabCorp and Quest Diagnostics both said they’ve ramped up their COVID-19 testing capacity. - How feds will divvy up $11B to states for COVID-19 testing
The White House has revealed how it plans to distribute $11 billion from the CARES ACT to support state testing. - CMS allows pharmacies to bill Medicare for COVID-19 tests
CMS implemented a temporary policy that allows pharmacies to bill Medicare for COVID-19 tests, a move that could increase the number of pharmacies able to offer diagnostic testing. - FDA gives emergency OK to Abbott’s COVID-19 antibody test
The FDA granted emergency use authorization for Abbott Laboratories’ new COVID-19 antibody test. - FDA approves first antigen, saliva COVID-19 tests
The FDA authorized two new types of diagnostic COVID-19 tests this week, the first antigen test and the first at-home test that uses saliva samples. - FDA clears development, sale of at-home COVID-19 tests
The FDA posted new guidelines that allow manufacturers to develop and market COVID-19 test kits that could be used by people at home and mailed to any lab in the country, a move the agency hopes will significantly increase U.S. testing capacity. - FDA tightens standards for COVID-19 antibody tests
The FDA strengthened rules for COVID-19 antibody tests after public health officials raised concerns over the quality of the tests, which were allowed on the market without FDA review.
More articles on supply chain:
AdventHealth cuts ties with lab after 35K COVID-19 test results were found to be unreliable
FDA approves another at-home COVID-19 test
7 recent drug, device recalls
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
